These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2039214

  • 1. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
    Jorgensen JH, Maher LA, Howell AW.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):600-2. PubMed ID: 2039214
    [Abstract] [Full Text] [Related]

  • 2. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L, Biedenbach DJ, Jones RN.
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains.
    Miyazaki S, Fujikawa T, Kanazawa K, Yamaguchi K.
    J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563
    [Abstract] [Full Text] [Related]

  • 4. In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae.
    Powell M, Williams JD.
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1871-3. PubMed ID: 3501940
    [Abstract] [Full Text] [Related]

  • 5. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
    Powell M, Seetulsingh P, Williams JD.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae.
    Cerami AT, Shungu DL.
    Antimicrob Agents Chemother; 1986 Jul; 30(1):179-80. PubMed ID: 3489437
    [Abstract] [Full Text] [Related]

  • 7. Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.
    Yourassowsky E, Van der Linden MP, Crokaert F.
    Chemotherapy; 1991 Jul; 37(1):38-42. PubMed ID: 2013240
    [Abstract] [Full Text] [Related]

  • 8. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S, Arroyo M, Pérez-Vázquez M, Aracil B, Lara N, Oteo J, Cercenado E, Campos J.
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [Abstract] [Full Text] [Related]

  • 9. [The prevalence of beta-lactamase negative ampicillin resistant Haemophilus influenzae in Mie Prefecture].
    Maruyama T, Yoshimura H, Nakamura A, Abe K, Moriguchi Y, Matsushima Y, Furukawa M, Nakano M, Morishita Y, Nobori T.
    Kansenshogaku Zasshi; 2004 Oct; 78(10):891-7. PubMed ID: 15560379
    [Abstract] [Full Text] [Related]

  • 10. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
    Billal DS, Hotomi M, Yamanaka N.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
    [No Abstract] [Full Text] [Related]

  • 11. Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.
    Jorgensen JH, Doern GV, Thornsberry C, Preston DA, Redding JS, Maher LA, Tubert T.
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):27-32. PubMed ID: 3259490
    [Abstract] [Full Text] [Related]

  • 12. In-vitro activity of imipenem against 100 strains of serotype b and nontypable Haemophilus influenzae, including strains resistant to ampicillin, chloramphenicol or both.
    Campos JM, Gill CJ, Ahonkhai VI.
    J Antimicrob Chemother; 1985 Nov; 16(5):549-54. PubMed ID: 3878361
    [Abstract] [Full Text] [Related]

  • 13. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY, Livermore DM.
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [Abstract] [Full Text] [Related]

  • 14. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [Abstract] [Full Text] [Related]

  • 15. [Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
    Furugo I, Takii M, Ueda M, Ishida M.
    Jpn J Antibiot; 2002 Jun; 55(3):302-10. PubMed ID: 12199114
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [Abstract] [Full Text] [Related]

  • 17. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
    García-Cobos S, Campos J, Lázaro E, Román F, Cercenado E, García-Rey C, Pérez-Vázquez M, Oteo J, de Abajo F.
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2564-73. PubMed ID: 17470649
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV, Brueggemann AB, Pierce G, Holley HP, Rauch A.
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [Abstract] [Full Text] [Related]

  • 19. Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.
    Seki H, Kasahara Y, Ohta K, Saikawa Y, Sumita R, Yachie A, Fujita S, Koizumi S.
    Chemotherapy; 1999 Feb; 45(1):15-21. PubMed ID: 9876205
    [Abstract] [Full Text] [Related]

  • 20. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M, Aguilar L, González N, Giménez MJ, Echeverría O, Cafini F, Sevillano D, Alou L, Coronel P, Prieto J.
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.